Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Flap structure-specific endonuclease | 0.0028 | 0.0862 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0021 | 0.0432 | 0.0402 |
Brugia malayi | Flap endonuclease-1 | 0.0028 | 0.0862 | 0.2371 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0031 | 0.0097 |
Schistosoma mansoni | intermediate filament proteins | 0.0029 | 0.0921 | 0.0511 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0028 | 0.0862 | 0.0833 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0021 | 0.0432 | 0.4704 |
Schistosoma mansoni | hypothetical protein | 0.0181 | 1 | 1 |
Schistosoma mansoni | lamin | 0.0029 | 0.0921 | 0.0511 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0123 | 0.0379 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0028 | 0.0862 | 1 |
Onchocerca volvulus | 0.0029 | 0.0921 | 0.5 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0021 | 0.0432 | 0.0402 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3239 | 0.2934 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0029 | 0.0921 | 0.2842 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0021 | 0.0432 | 0.0402 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0021 | 0.0432 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0921 | 0.2842 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0021 | 0.0432 | 0.0992 |
Plasmodium falciparum | flap endonuclease 1 | 0.0028 | 0.0862 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Echinococcus granulosus | dna polymerase eta | 0.0021 | 0.0432 | 0.0402 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0021 | 0.0432 | 0.1334 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0028 | 0.0862 | 1 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0028 | 0.0862 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0068 | 0.3239 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3239 | 0.2934 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0028 | 0.0862 | 0.266 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3239 | 0.2934 |
Brugia malayi | RNA binding protein | 0.0068 | 0.3239 | 1 |
Echinococcus granulosus | lamin dm0 | 0.0029 | 0.0921 | 0.0892 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0028 | 0.0862 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Echinococcus multilocularis | geminin | 0.0181 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0068 | 0.3239 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0021 | 0.0432 | 0.4704 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0.0432 | 0.5 |
Echinococcus granulosus | flap endonuclease 1 | 0.0028 | 0.0862 | 0.0833 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Trypanosoma brucei | unspecified product | 0.0021 | 0.0432 | 0.4704 |
Echinococcus multilocularis | lamin dm0 | 0.0029 | 0.0921 | 0.0892 |
Echinococcus multilocularis | musashi | 0.0029 | 0.0921 | 0.0892 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0028 | 0.0862 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0889 | 0.2745 |
Brugia malayi | TAR-binding protein | 0.0068 | 0.3239 | 1 |
Entamoeba histolytica | Flap nuclease, putative | 0.0028 | 0.0862 | 1 |
Echinococcus granulosus | lamin | 0.0029 | 0.0921 | 0.0892 |
Echinococcus granulosus | tar DNA binding protein | 0.0068 | 0.3239 | 0.3217 |
Onchocerca volvulus | 0.0029 | 0.0921 | 0.5 | |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0028 | 0.0862 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0.0432 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0432 | 0.1334 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3239 | 0.2934 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0021 | 0.0432 | 0.0992 |
Schistosoma mansoni | flap endonuclease-1 | 0.0025 | 0.0702 | 0.0282 |
Brugia malayi | intermediate filament protein | 0.0029 | 0.0921 | 0.2561 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0029 | 0.0921 | 0.2561 |
Echinococcus multilocularis | dna polymerase eta | 0.0021 | 0.0432 | 0.0402 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0068 | 0.3239 | 1 |
Schistosoma mansoni | lamin | 0.0029 | 0.0921 | 0.0511 |
Schistosoma mansoni | tar DNA-binding protein | 0.0068 | 0.3239 | 0.2934 |
Loa Loa (eye worm) | intermediate filament protein | 0.0029 | 0.0921 | 0.2842 |
Echinococcus granulosus | intermediate filament protein | 0.0029 | 0.0921 | 0.0892 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Echinococcus multilocularis | lamin | 0.0029 | 0.0921 | 0.0892 |
Loa Loa (eye worm) | TAR-binding protein | 0.0068 | 0.3239 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.0021 | 0.0432 | 0.0402 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0432 | 0.4704 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0021 | 0.0432 | 0.4704 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0.0432 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0021 | 0.0432 | 0.4704 |
Schistosoma mansoni | hypothetical protein | 0.0181 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0068 | 0.3239 | 0.3217 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.